Home/Filings/4/0001628280-25-013196
4//SEC Filing

Warren Eric 4

Accession 0001628280-25-013196

CIK 0001434868other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 5:16 PM ET

Size

20.1 KB

Accession

0001628280-25-013196

Insider Transaction Report

Form 4
Period: 2025-03-14
Warren Eric
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-03-14+191,000191,000 total
    Exercise: $1.50Exp: 2035-03-14Common Stock (191,000 underlying)
  • Award

    Common Stock

    2025-03-14+213,000372,759 total
Footnotes (1)
  • [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2025.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001916048

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:16 PM ET
Size
20.1 KB